RY_SW01 cell injection

DRUG2 trials

Sponsors

Jiangsu Renocell Biotech Company

Conditions

Lupus NephritisSystemic Sclerosis

Phase 1

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

RecruitingNCT06058091

Jiangsu Renocell Biotech CompanySystemic Sclerosis

Start: 2023-09-22End: 2035-12-31Target: 81Updated: 2024-01-18

Phase 2

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

RecruitingNCT06058078

Jiangsu Renocell Biotech CompanyLupus Nephritis

Start: 2023-08-17End: 2028-12-31Target: 60Updated: 2024-01-18